MUSA

Author
Team Zorg Enablers
Published on
15-11-2020
Category
Implementations | Treatment & Guidance

 

Surgical robots are used in more and more hospitals. A close collaboration between plastic surgeons at Maastricht UMC+ (MUMC+), and technicians at both TU Eindhoven (TUe) and spin-off company Microsure, the first microsurgery robot in the world was developed. This robot, called ‘MUSA’, consists of a set of robot hands, operated by surgeons. Besides that, the robot filters out the tremors of the human hand. The robot thus makes microsurgical operations more workable, and facilitates new interventions. This should lead to better results for the patients and lower healthcare expenses, because less after treatments and repeat surgeries are needed. There are also benefits for the surgeon: by avoiding standing still in an unnatural posture for a long time, back and neck pains are prevented. ‘Microsurgery actually encompasses all surgical procedures that require a microscope. The technique is increasingly refined and creates less and less damage. There is even super microsurgery, in which blood vessels and lymph vessels are stitched together. Initially it was a rather exclusive specialty, but MUSA ensures more and more surgeons are able to perform sophisticated microscopic surgeries,’ states Tom van Mulken, plastic surgeon and co-founder of Microsure.

More and more is possible with microsurgery, but the right means must be available. A much-used surgical robot, such as the Da Vinci robot, is developed primarily for laparoscopic surgeries and thus not fully capable to execute microsurgical operations. Van Mulken: ‘The basic idea is that if a surgeon has to enhance their eyes that much to operate on a microlevel, then the hands should be able to be enhanced to a comparable scale. If you think about it, it’s very logical to perform microsurgery with a steady robot.’ The development of MUSA began in 2007, in cooperation with Raymond Cau, student at the Technische Universiteit Eindhoven, and van Mulken. The combination of technical and medical knowledge kicked the project into gear.

Through subsidies a first prototype was developed, which lead to the founding of spinoff company Microsure in 2016. This way, investments could be collected to cover Microsure’s expenses during the continued development. The first and second generation prototypes were subjected to extensive scientific research within the MUMC+. Out of a clear and solid long-term vision and strategy, a scientific foundation was slowly created in order to transition into human experiments. In 2017, the first patients were successfully treated with the robot at the MUMC+[1]. Van Mulken: ‘For the first surgery, we deliberately chose a procedure that posed a low risk to the patient, but was very complex at the same time. That way, we could immediately showcase MUSA’s added value.

Based on the long-term vision, the organisations created room to experiment and continue development on the prototypes. A conscious choice, because people are often at risk of making promises they cannot keep. Besides, the right people could be engaged in order to make the first phase a success, where much attention was paid to creating support. ‘This is only achievable if you can achieve success together. We have always tried to include everyone in the benefits, and to acknowledge everyone,’ says Van Mulken. MUSA’s development follows a technology-pull strategy, meaning the surgical robot will not feature all the most advanced gadgets immediately, only the necessary ones. And use is made of reusable instruments, in order to reduce the costs.

Previously, MUSA was only used for study purposes, but in the meantime the surgical robot is CE-certified, meaning it can officially be put on the market. And with new investment monies form a recently concluded second round of investments, the further industrialisation of MUSA is being worked on. In doing so, they are providing microsurgeons with the opportunity to experience working with this precision tool and perform other types of surgeries. They are focussing the Netherlands, Germany, Belgium, and the Scandinavian countries first. With MUSA, it should become possible to treat patients better and to offer more people this specialised care.

Microsure

Drs. Tom van Mulken has been a plastic, reconstructive, and hand surgeon in both the Maastricht UMC+ and the Zuyderland MC sends 2009. Within the MUMC+ he conducts research into the development of a microsurgery robot, and is a co-founder of Microsure.